Clinical Trials Browser

Phase 2 × Waldenstrom Macroglobulinemia × Sra protein, Drosophila × Clear all

NCT07464210 2026-03-11

Nemtabrutinib, Bortezomib, and Rituximab for WM

Phase 2 Not yet recruiting

Waldenstrom Macroglobulinemia